Document is current
Any future updates will be listed below
-
Authors
Howden, Colin W.
Sheldon, Kely L. https://orcid.org/0000-0002-0779-7580
Almenoff, June S.
Chey, William D.
- License Information
-
More Information
Article History
Received: 23 June 2021
Accepted: 8 November 2021
First Online: 4 December 2021
Declarations
:
: Dr. CH is a Professor Emeritus, Department of Medicine, University of Tennessee College of Medicine, Memphis, TN. He serves as a consultant to RedHill Biopharma, Phathom, Allakos, Ironwood, EndoStim. Speaker for RedHill Biopharma, Alnylam, Sanofi / Genzyme. Stockholder of Antibe Therapeutics. Dr. WC is a Nostrant Professor of Gastroenterology & Nutrition Sciences, Director of the GI Physiology Laboratory, Director of the Digestive Disorders Nutrition & Lifestyle Program, and Co-Director of the Michigan Bowel Control Program. He serves as a Board Member for the American College of Gastroenterology, International Foundation of GI Disorders, Rome Foundation. He serves as a consultant to Abbvie, Allakos, Alnylam, Arena, Biomerica, Gemelli, Ironwood, Nestle, QOL Medical, Phathom, Progenity, Redhill Biopharma, Salix/Valeant, Takeda, Urovant, and Vibrant. His research is supported by the NIH, FDA, Biomerica, Commonwealth Diagnostics, QOL Medical, and Salix. He is a shareholder of GI on Demand and Modify Health. Drs. KS and JA are employees of RedHill Biopharma, Inc., Raleigh, NC USA and are stockholders of RedHill Biopharma. Dr. Howden is a consultant for RedHill Biopharma, Phathom Pharmaceuticals, Ironwood, Clexio, Allakos, and Alfasigma. He is a speaker for RedHill Biopharma, Alfasigma, and Alnylam. He owns stock in Antibe Therapeutics. Dr. Sheldon is an employee of RedHill Biopharma, Inc., 8045 Arco Corporate Drive, Suite 200, Raleigh, NC 27617, USA. Dr. Almenoff is an employee of RedHill Biopharma, Inc., 8045 Arco Corporate Drive, Suite 200, Raleigh, NC 27617, USA. Dr. Chey, Board member: American College of Gastroenterology, GI on Demand, International Foundation of Functional GI Disorders, Rome Foundation; Consultant: AbbVie, Alfasigma, Allakos, Alnylam, Bayer, Biomerica, Cosmo, IM Health, Ironwood, QOL Medical, Phathom, RedHill Biopharma, Salix/Valeant, Takeda, Urovant, Vibrant; Grant/Research Support: Bioamerica, Commonwealth Diagnostics International, QOL Medical, Salix; Stock/Stock options: GI on Demand, Modify Health.
